Paclitaxel - C47h51no14, 33069-63-4 | Advanced Treatment For Ovarian Cancer, Node-positive And Metastatic Breast Cancer, Non-small Cell Lung Cancer, And Aids-related Kaposi's Sarcoma

Ovarian cancer: The medication is used alone or in combination with cisplatin (PlatinolAR) for advanced ovarian cancer (cancer that has spread or is starting to spread to other parts of the body).

Node-positive breast cancer: Paclitaxel can be part of a chemotherapy regimen containing doxorubicin (AdriamycinAR) for node-positive breast cancer that has spread to a lymph node after breast cancer surgery.

Mestatic breast cancer: The drug can treat metastatic breast cancer that has spread to other parts of the body after other chemotherapy regimens have failed.

Recurrent breast cancer: Paclitaxel can be used to treat breast cancer that has returned within six months of chemotherapy after breast cancer surgery.

Non-small cell lung cancer: Paclitaxel is often used with cisplatin to treat non-small cell lung cancer (NSCLC) that is not likely to be cured by surgery or radiation.

AIDS-related Kaposi's sarcoma: The medication can be used to treat AIDS-related Kaposi's sarcoma that has not responded to other treatments.

Cas No.: 33069-63-4
MF: C47H51NO14
MW: 853.92
Appearance: White powder.